Human Pathology
Volume 37, Issue 1 , Pages 9-15 , January 2006

Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma

  • Rashna Madan

      Affiliations

    • Department of Pathology, Montefiore Medical Center, Bronx, NY 10467, USA
    • These authors made an equal contribution to this work.
    • ,
  • Matthew B. Smolkin

      Affiliations

    • Department of Pathology, St Peter's Hospital, Helena, MT 59061, USA
    • These authors made an equal contribution to this work.
    • ,
  • Rubina Cocker

      Affiliations

    • Department of Pathology, Montefiore Medical Center, Bronx, NY 10467, USA
    • ,
  • Rana Fayyad

      Affiliations

    • Department of Biometrics and Reporting, Pfizer, New York, NY 10017, USA
    • ,
  • Maja H. Oktay

      Affiliations

    • Department of Pathology, Montefiore Medical Center, Bronx, NY 10467, USA
    • Corresponding Author InformationCorresponding author.

Received 12 July 2005 ,Accepted 17 September 2005.

References 

  1. Giancotti FG, Rouslahti E. Integrin signaling. Science. 1999;285:1028–1032
  2. Carragher NO, Frame MC. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 2004;14:241–249
  3. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci. 2003;116:1409–1416
  4. Spencer VA, Davie JR. Signal transduction pathways and chromatin structure in cancer cells. J Cell Biochem Suppl. 2000;35:27–35
  5. Schaller MD. Paxillin: a focal adhesion-associated adaptor protein. Oncogene. 2001;20:6459–6472
  6. Glenney JR, Zokas L. Novel tyrosine kinase substrates for Rous sarcoma virus–transformed cells are present in the membrane skeleton. J Cell Biol. 1989;101:2401–2408
  7. Brown MC, Turner CE. Paxillin: adapting to change. Physiol Rev. 2004;84:1315–1339
  8. Turner CE. Paxillin interaction. J Cell Sci. 2000;113:4139–4140
  9. Scibelli A, D'Angelo D, Pelagalli A, et al. Expression levels of focal adhesion-associated proteins paxillin and p130 CAS in canine and feline mammary tumors. Vet Res. 2003;34:193–202
  10. Salgia R, Li JL, Ewaniuk DS, et al. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene. 1999;18:76–77
  11. Cance WG, Harris JE, Iacocca MV, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotype. Clin Cancer Res. 2000;6:2417–2423
  12. Kornberg LJ. Focal adhesion kinase expression in oral cancers. Head Neck. 1998;20:634–639
  13. Weiner TM, Liu ET, Craven RJ, et al. Expression of focal adhesion kinase gene in invasive cancer. Lancet. 1993;342:1023–1025
  14. Oktay MH, Oktay K, Hamele-Bena D, et al. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol. 2003;34:240–245
  15. Grisaru-Granovsky S, Salah Z, Maoz M, et al. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer. 2005;113:372–378
  16. Aronsohn MS, Brown HM, Hauptman G, et al. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope. 2003;113:1944–1948
  17. Miyazaki T, Kato H, Nakajima M, et al. FAK overexpression is correlated with tumor invasiveness and lymph node metastasis in esophageal squamous cell carcinoma. Br J Cancer. 2003;89:140–145
  18. Beviglia L, Golubovskaya V, Xu L, et al. Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. Biochem J. 2003;373:201–210
  19. Belsches-Jablonski AP, Biscardi JS, Peavy DR, et al. Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene. 2001;20:1465–1475
  20. Ito Y, Kawakatsu H, Takeda T, et al. Activation of c-Src is inversely correlated with biological aggressiveness of breast carcinoma. Breast Cancer Res Treat. 2002;76:261–267
  21. Lotz M, Wang HH, Cance W, Matthews J, Pories S. Epidermal growth factor stimulation can substitute for c-Src overexpression in promoting breast carcinoma invasion. J Surg Res. 2003;109:123–129
  22. Chen HY, Shen CH, Tsai YT, et al. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol. 2004;24:10558–10572
  23. Turner CE. Paxillin and focal adhesion signaling. Nat Cell Biol. 2000;2:E231–E236
  24. Pelagalli A, Scibelli A, Lombardi P, et al. Expression of the focal adhesion protein paxillin in normal and breast cancer tissues. Vet Res Commun. 2003;27(Suppl 1):343–346
  25. Ayaki M, Komatsu K, Mukai M, et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res. 2001;7:3106–3112
  26. Bowden ET, Barth M, Thomas D, et al. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 1999;18:4440–4449
  27. Onodera Y, Hashimoto S, Hashimoto A, et al. Expression of AMAP1, and ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J. 2005;24:963–973
  28. Hicks D, Yoder B, Short S, et al. The expression of the focal adhesion protein paxillin in breast cancer correlates with HER2 amplification and may help predict a better response to chemotherapy. Mod Pathol. 2005;(Suppl 1):36A

PII: S0046-8177(05)00531-9

doi: 10.1016/j.humpath.2005.09.024

Human Pathology
Volume 37, Issue 1 , Pages 9-15 , January 2006

Article Tools

* Image Usage & Resolution